Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Other Working Capital Changes (2016 - 2025)

Tg Therapeutics has reported Other Working Capital Changes over the past 10 years, most recently at -$34.1 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$34.1 million for Q4 2025, down 513.39% from a year ago — trailing twelve months through Dec 2025 was $6.4 million (down 63.45% YoY), and the annual figure for FY2018 was $1.6 million, changed.
  • Other Working Capital Changes for Q4 2025 was -$34.1 million at Tg Therapeutics, down from $38.6 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for TGTX hit a ceiling of $38.6 million in Q3 2025 and a floor of -$34.1 million in Q4 2025.
  • Median Other Working Capital Changes over the past 5 years was -$38000.0 (2022), compared with a mean of $871000.0.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 29100.0% in 2023 and later skyrocketed 297.79% in 2024.
  • Tg Therapeutics' Other Working Capital Changes stood at -$1.9 million in 2021, then tumbled by 325.03% to -$8.1 million in 2022, then soared by 157.16% to $4.6 million in 2023, then crashed by 220.67% to -$5.6 million in 2024, then tumbled by 513.39% to -$34.1 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$34.1 million (Q4 2025), $38.6 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.